Malaria’s Achilles’ Heel: Target ARK1 Kinase to Halt Parasite Replication
Malaria still claims about 610,000 lives each year; scientists have identified ARK1, an Aurora-related kinase in Plasmodium parasites, as essential for their unusual cell division and spindle formation. Inactivating ARK1 disrupts replication in both human and mosquito stages, making it a promising parasite-specific drug target. The work, published in Nature Communications, could help develop new antimalarial therapies that spare human cells.